1
Views
0
CrossRef citations to date
0
Altmetric
Original Article

The Effect on Different Clotting Factors of Short-Term Treatment with Phenylindanedione

Pages 247-252 | Received 17 Sep 1961, Published online: 28 Aug 2009

References

  • Aas K. Prokonvertin og konvertin Thesis. Akad. Trykningssentral, Oslo 1952; 21
  • Blombäck B., Blombäck M. Purification, of human aid bovine fibrinogen. Ark. Kemi 1956; 10: 415
  • Egeberg O. Assay of antihemophilic A. B and C factors by one stage cephalin systems. Scand. J. clin. Lab. Invest. 1961; 13: 140
  • Hjort P.F. Intermediate reactions in the coagulation of blood with, tissue thromboplastin. Convertion, accelerin, prothorombinase Ibid. 1957; 9
  • Rapaport S. I., Owren P.A. A simple specific one-stage prothrombin assay using Russell's viper venom in cephalin suspension. J. Lab. clin. Med. 1955; 46: 89
  • Jacobsson K. Studies on the determination of fibrinogen in human blood plasma. Scand. J. clin Lab. Invest. 1955; 7
  • Langdell R. D., Wagner R. H., Brinkhous K. M. Effect of antihemophilic factor on one-stage clotting tests. J. Lab. clin. Med. 1953; 41: 637
  • Naye R. L. Plasma thromboplastin component: Influence of coumarin compounds and vitamin K on its activity in serum. Proc. Soc. exp. Bio (N.Y.) 1956; 91: 101
  • Burstein M., Guinand A. Hemophilioid factors: Acquired deficiencies in several hemorrhagic states. Ibid. 1957; 94: 623
  • Owren P. A. The coagulation of blood. Investigations on a new clotting factor. Thesis. Acta med. scald. 1947; 128
  • Burstein M., Guinand A. A new method for controlling anticoagulant therapy. Lancet 1959; ii: 754
  • Rodermund O.-E., Schneider W, Egli H. Über das verhalten des Hageman-Faktors und des Plasma-Thromboplstin-Antecedent (PTA) unter Hydroxy-Cumarin und Phenyl-Indandiongaben. Thromb. Diath. haemorrh. 1961; 5: 595
  • Waaler B.A. Contact activation in the intrinsic blood clotting system. Thesis. Scand. J. clin. Lab. Invest. 1959; 11

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.